EDN1 and Hyperglycemia: Additionally, adipocyte-derived circulating FFA and hyperglycemia-induced advanced glycation end products (AGE) lead to increased oxidative stress, thereby limiting NO bioavailability, as well as increased production of vasoconstrictor factors such as thromboxane A2 and ET-1 (Creager et al., 2003).